Hypothesis The Enterovirus Theory of Disease Etiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Critical Review, Hanson et al (2021)

Hoopoe

Senior Member (Voting Rights)
Abstract

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex, multi-system disease whose etiological basis has not been established. Enteroviruses (EVs) as a cause of ME/CFS have sometimes been proposed, as they are known agents of acute respiratory and gastrointestinal infections that may persist in secondary infection sites, including the central nervous system, muscle and heart. To date, the body of research that has investigated enterovirus infections in relation to ME/CFS supports an increased prevalence of chronic or persistent enteroviral infections in ME/CFS patient cohorts than in healthy individuals. Nevertheless, inconsistent results have fueled a decline in related studies over the past two decades.

This review covers the aspects of ME/CFS pathophysiology that are consistent with a chronic enterovirus infection and critically reviews methodologies and approaches used in past EV-related ME/CFS studies. We describe the prior sample types that were interrogated, the methods used and the limitations to the approaches that were chosen.

We conclude that there is considerable evidence that prior outbreaks of ME/CFS were caused by one or more enterovirus groups. Furthermore, we find that the methods used in prior studies were inadequate to rule out the presence of chronic enteroviral infections in individuals with ME/CFS. Given the possibility that such infections could be contributing to morbidity and preventing recovery, further studies of appropriate biological samples with the latest molecular methods are urgently needed.
Paragraph breaks added.

https://www.frontiersin.org/articles/10.3389/fmed.2021.688486/abstract
 
Last edited by a moderator:
To me, the lack of a definite 'all PWME have this virus' finding means that ME is not a viral disease. Viral infections might trigger ME in people susceptible to developing ME, and might increase the severity in PWME who are susceptible to that, but that there are also other PWME who triggered from other factors and who don't have a chronic viral infection or hidden viral fragments or other excuses for why a guilty virus can't be found.

If I was allocating ME research funding, viral hypotheses wouldn't be at the top of my list.
 
If I was allocating ME research funding, viral hypotheses wouldn't be at the top of my list.
Pathogens of all sorts would be considered for my list of ME/CFS causes, just as they would be for MS. I fully would expect multiple infectous agents to be behind discreet ME/CFS cases, i.e, enteroviruses cause ME for some, other viruses for some, bacteria for some, parasites for some, etc.

Moreover, I'd be looking in tissue whenever possible.
 
I'm skeptical of enteroviruses as a category of pathogens, rather than pathogens with the ability to infect the GI tract. My understanding of enteroviruses is that it's a class of viruses known to do that, but viruses not in that category can still infect the gut, like Covid-19 does. And GI symptoms have been one of the strongest predictors of LC so far, although that's limited because of how little the right questions are asked.

So is that really about the family of viruses known to do that? Or any pathogen that can take hold in there, which is an overlap but not the same thing. Because that would not explain LC, or mono, for that matter. Unless it's just a chance interaction that allows an enterovirus to go into rage mode.
 
To me, the lack of a definite 'all PWME have this virus' finding means that ME is not a viral disease. Viral infections might trigger ME in people susceptible to developing ME, and might increase the severity in PWME who are susceptible to that, but that there are also other PWME who triggered from other factors and who don't have a chronic viral infection or hidden viral fragments or other excuses for why a guilty virus can't be found.

If I was allocating ME research funding, viral hypotheses wouldn't be at the top of my list.

Enteroviruses are known to cause diseases of the brain and heart as well as hand foot and mouth disease and summer flu. They also have mechanisms for evading the immune system. They are a seriously neglected class with the CDC taking far too long to be forced to admit that acute flaccid paralysis is enteroviral because of a conforting feeling they are not a cause of serious disease any more. Remember coronaviruses were just the common cold 2 years ago.

Viruses are way more complicated organisms to detect and study than bacteria. Fifty years ago we were taught about a type of plant virus that was just a naked piece of RNA and the lecturer said it gave him nightmares if something like that was infecting humans.

A virus that is very good at evading the immune system is a very successful virus. Causing a subclinical infection then finding a niche and causing barely noticeable ill health until it can get a better foothold if there is disruption to the body is a very good strategy.

I don't think that research funds for viruses are the way to go - actually looking at how the disease is experienced so we are all talking about the same thing is the most important thing - but there is a good chance many things that go wrong in the body are triggered by viruses.
 
I had a sudden viral onset, and whatever was occurring in my immune system during that time period seems to have activated h pylori infection. I might have been asymptomatic w h pylori for years, but the viral onset altered my immune system and brought it to surface.

Just a theory of mine of course, but a big coincidence if it didn't. My gut was increasingly becoming worse 5 years after onset until I was treated.

I don't think that it's an ongoing viral infection in my case, but an altered immune system that occurred after the initial infection.
 
The main argument for the role of enteroviruses in ME are the past epidemics where such a connection was hypothesized. But those do not seem to appear anymore and instead millions of patients got ill outside recognized epidemics, without clear seasonality etc. I haven't found a discussion on why this in the paper.

Then there is the fact that other viruses such as EBV, Ross River and perhaps also SARS-CoV-2 seems to trigger ME/CFS. The author try to deal with this objection as follows:
it is possible that individuals who report ME/CFS after mononucleosis or other herpesviral infections may have also had an inciting enterovirus infection before or after the herpesvirus infection. In fact, one may speculate that an undetected enteroviral infection could make an individual more susceptible to symptomatic cases of EBV infection, for example. Most individuals are infected with EBV as children, yet a number of patients have reported an adult-onset EBV infection as triggering their ME/CFS. Perhaps these adult cases are actually mis-diagnosed reactivated infections

They also argue that:
Multiple aspects of the ME/CFS pathophysiology, especially related to autonomic dysfunction, are reminiscent of chronic neurotropic enterovirus-related diseases and clinical outcomes
I'm not convinced. Except for post-polio syndrome, enterovirus-related diseases seem quite different from ME/CFS.
 
I had a sudden viral onset, and whatever was occurring in my immune system during that time period seems to have activated h pylori infection. I might have been asymptomatic w h pylori for years, but the viral onset altered my immune system and brought it to surface.

Just a theory of mine of course, but a big coincidence if it didn't. My gut was increasingly becoming worse 5 years after onset until I was treated.

I don't think that it's an ongoing viral infection in my case, but an altered immune system that occurred after the initial infection.
Ditto my daughter.
 
Merged thread

Sorry, but I think this is a dead end. (Not necessarily a knock against Maureen Hanson, but rather against this line of research).

 
Last edited by a moderator:
What leads you to that conclusion?

I think it is reasonable. The only real reason why anyone is interested in enteroviruses in ME is that way back in the time the Royal Free outbreak neurological features raised the suggestion of a novel enterovirus. But it was never found and the neurological features are not recognised today as part of ME as we know it. So it seems a red herring. People have looked for enterovirus for decades and not found anything convincing.

If there is such a thing as flogging a dead horse this might be a strong candidate.
 
The main argument for the role of enteroviruses in ME are the past epidemics where such a connection was hypothesized. But those do not seem to appear anymore and instead millions of patients got ill outside recognized epidemics, without clear seasonality etc. I haven't found a discussion on why this in the paper.

The main reason there are not large enteroviral epidemics anymore are because of vaccination for polioviruses. Hand foot and mouth disease still runs rampant through nurseries though and summer flu from Coxsackie B is common. In fact one of the reasons they said enteroviruses were not involved in ME is that everyone is exposed to them.

Strangely, the other reason is that outbreaks are not reported. Acute flaccid paralysis in children has been sweeping the world for a good few years now. There was speculation last year if the lockdowns would reduce the numbers but I have not seen anything since whether it has or not.

There have been epidemics of atypical polio in India that I saw mentioned too.

Not specifically about ME but there is a strange aura around enteroviruses. They are somehow considered unimportant compared to others in the way that ME is not given the same status as MS and RA. Yet they are a complex, fascinating class of virus that are worthy of study in their own right.
 
On the studies undertaken to find (latent) enteroviruses in people with ME/CFS, with a conclusion that more and better studies are needed:
To date, ME/CFS studies reporting the use of tissue culture for EV detection have used CSF and feces in 1 and 4 studies, respectively (115118). The singular CSF study reported two EV infections in a cohort of 4 patients, while the 4 fecal studies reported an increased EV infection prevalence in 2 of 4 studies, with cohorts ranging from a 22–25% prevalence across patient cohorts (Table 1).

Although the prevalence of EV infections in these studies was generally shown to be significantly increased compared to healthy control cohorts, limitations in patient sample types and cell culture models may have led to findings that underrepresent the prevalence of EV infections in patient cohorts. Of the five cell culture studies, one study used only one cell type (115), 3 studies used two cell types (115117) and one study used three cell types (118).

The most comprehensive study, which utilized three cell culture types, included green monkey kidney cells, RD cells and HeLa cells, which together supply a diversity of enterovirus receptors including CAR, CD155 and DAF. These cultures therefore detect a wide diversity of enteroviruses although the system is still not totally comprehensive. No enterovirus-positive fecal samples were found within a cohort of 12 ME/CFS patients (118) when the triple-cell culture method was used. EVs may be absent in these patients, but lack of detection might also be attributed to the presence of an enterovirus that uses an alternative receptor as well as the low likelihood of detecting EV infections in the stool samples of chronically ill patients with persistent infections in secondary sites such as muscle and brain tissue. Furthermore, the investigators were searching for CPE, and EVs present in chronic infections commonly undergo genetic changes which reduce CPE. An example of the inadequacy of CPE is a report that inoculated cell cultures were negative for CPE production in human fetal lung fibroblast and tertiary monkey kidney cell cultures but were nevertheless positive upon RT-PCR (119).

Two studies utilized Hep-2, VERO, and monkey kidney tissue cultures for identification of enterovirus from CSF and feces from 4 and 76 patients, respectively. Innes (115) identified enterovirus in 2 of 4 CSF samples and one of 4 feces samples (115). Yousef et al. (116) found that 17/76 patients tested positive for enterovirus infection while only 2/30 controls tested positive (116).

Studies reporting the absence of enterovirus infections in ME/CFS patient cohorts using tissue culture approaches had small sample sizes and incomprehensive cell culture systems. Small sample sizes along with the fact that EVs harboring 5′UTR deletions do not produce CPE means that no definitive conclusion can be made about the absence of EVs from the data in these studies. Furthermore, fecal samples usually identify only acute enterovirus infections and not chronic ones that might be in secondary infection sites. Nevertheless, some studies that screened suboptimal sample types with culture methods did find an increased prevalence of EV infections, which might have been due to inclusion of patients who were still in the acute phase of illness.

The enteroviral capsid protein VP1 is commonly used for identification of enteroviral virions in ME/CFS patient tissues. In total, 5 studies have used this technique on a variety of patient sample types, including muscle, gastrointestinal, and brain tissue (Table 1, Supplementary Table 1) (20, 54, 98, 99, 137). Of these, 4 out of 5 studies identified the presence of VP1 capsid proteins in patient tissue. The muscle tissue study did not detect VP1 staining in samples of a cohort of 30 ME/CFS patients, despite RT-PCR signals that indicated the presence of EV-RNA in 13 of the same 30 patients. The authors suggested that the difference in PCR and VPI immunochemistry resulted from persistent but latent enteroviral infection in patient muscle tissues, in which no detectable amount of virion particles were being produced (137).

The remaining 4 studies showed positive VP1 staining in both gastrointestinal and brain tissues (20, 54, 98, 99). Gastrointestinal samples exhibited positive staining rate of 82% in two patient cohorts (n = 165, n = 416). Comparative cohorts for these two studies were healthy controls (n = 34) and patients with functional dyspepsia (FD) (n = 66), which displayed a positive VP1 staining rate of 20 and 83%, respectively (20, 99). Both the ME/CFS and FD patient cohorts showed dsRNA staining for 64 and 63% of patients, respectively (54). Because persistent/chronic EV infections with reduced CPE and viral replication typically have a 1:1 ratio between enteroviral positive and negative RNA strands, finding a high rate of dsRNA in patient tissues indicates the likely presence of persistent enteroviral infections. One study found VP1 in fibroblasts of small blood vessels in the cerebral cortex and in a small fraction of glial cells in brain (98), while another detected VP1 instead in the pontomedullary junction, medial temporal lobe, lateral frontal cortex, occipital lobe, cerebellum and midbrain (99).

I think it's reasonable to hypothesise that persistent enteroviruses can cause ME/CFS, and to investigate the hypothesis. I think it's less reasonable to assume that a range of non-enteroviral infections either can't similarly trigger an immune response that causes ME/CFS, or can't trigger a persistent enteroviral infection to produce ME/CFS.
 
Back
Top Bottom